Percutaneous Coronary Intervention in Patients With End-Stage Liver Disease
Autor: | Shilpkumar Arora, Mauricio G. Cohen, Apurva Badheka, Nileshkumar J. Patel, Ghanshyam Palamaner Subash Shantha, Abhishek Deshmukh, Alex P. Rodriguez, Vikas Singh, Cindy L. Grines, Eduardo de Marchena, Abhijit Ghatak |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male medicine.medical_specialty Time Factors Adolescent medicine.medical_treatment Population Coronary Artery Disease 030204 cardiovascular system & hematology Coronary Angiography Coronary artery disease End Stage Liver Disease 03 medical and health sciences Liver disease Young Adult 0302 clinical medicine Percutaneous Coronary Intervention Postoperative Complications Internal medicine medicine Humans 030212 general & internal medicine Myocardial infarction education Propensity Score Survival rate Aged Retrospective Studies Aged 80 and over education.field_of_study business.industry Mortality rate Percutaneous coronary intervention Drug-Eluting Stents Middle Aged medicine.disease United States Survival Rate Treatment Outcome Conventional PCI Cardiology Female Morbidity Cardiology and Cardiovascular Medicine business |
Zdroj: | The American journal of cardiology. 117(11) |
ISSN: | 1879-1913 |
Popis: | The objective of our study was to assess patients with end-stage liver disease undergoing percutaneous coronary intervention (PCI) and determine the rates and trend of complications and in-hospital outcomes. Data were obtained from the Nationwide Inpatient Sample 2005 to 2012. We identified all PCIs performed in patients with diagnosis of cirrhosis during the study period by the International Classification of Diseases, Ninth Revision, Clinical Modification codes. Preventable procedural complications were identified by Patient Safety Indicators. Propensity scoring method was used to establish matched cohorts to control for imbalances and account for differences that may have influenced treatment outcomes. A total of 1,051,242 PCIs were performed during the study period, of these, 122,342 were done on subjects with a formal diagnosis of cirrhosis. Bare-metal stents (BMS) were more likely to be used in patients who presented with ST-elevation myocardial infarction (19.73 vs 13.58, p |
Databáze: | OpenAIRE |
Externí odkaz: |